CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney...
Phase 3
Barcelona, Spain and 17 other locations
people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD)....
Phase 1
Barcelona, Spain and 9 other locations
Roxadustat is a licensed medicine to treat anemia in adults with chronic kidney disease (CKD). Anemia is a low level of red blood c...
Phase 3
Esplugues de Llobregat, Spain and 42 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Barcelona, Spain and 325 other locations
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...
Phase 2
Barcelona, Spain and 146 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
L'Hospitalet de Llobregat, Spain and 295 other locations
The primary objective of this study is to evaluate the safety of tolvaptan in pediatric subjects with autosomal recessive polycystic kidney ...
Phase 3
Barcelona, Spain and 22 other locations
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney...
Phase 2
Barcelona, Spain and 118 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Barcelona, Spain and 338 other locations
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys...
Phase 2
Barcelona, Spain and 156 other locations
Clinical trials
Research sites
Resources
Legal